Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05109442
Title Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Affimed GmbH
Indications

pancreatic adenocarcinoma

lung non-small cell carcinoma

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

hepatocellular carcinoma

Therapies

AFM24 + Atezolizumab

Age Groups: senior | adult
Covered Countries USA | ESP


No variant requirements are available.